Subscribe now

Health

Ketamine ingredient improves severe depression in large trial

By Clare Wilson

5 May 2018

Ketamine

Could a form of ketamine treat depression?

Voisin/Phanie/REX/Shutterstock

The drug ketamine may have moved a step closer to routine use as an antidepressant. Positive – if modest – results from a large trial of an intranasal spray based on ketamine were announced by pharmaceutical giant Janssen today.

The firm is developing the treatment for people with severe depression who aren’t helped by existing medication or who are suicidal. If everything goes to plan, the medicine could be available next year in the US and Europe.

Ketamine has long been used as an anaesthetic in people and animals. Some people also…

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, subscribe today with our introductory offers

Popular articles

Trending New Scientist articles

Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop